21.43 USD
↘ 0.01 (0.05%)AT CLOSE (11:59 AM EDT)
Sutro Biopharma, Inc. (STRO) trades at $21.44 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (174.8%) and a bullish Golden Cross on the moving averages. Furthermore, STRO is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 26, 2026.